Insider Trading activities of Nile Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nile Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nile Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Nile Therapeutics, Inc. since 2005. The reporting company's ticker symbol is CAPR. The reporting company's CIK number is 1133869.
The total value of stock buying since 2005 is $15,336,948.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $3,319.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Nile Therapeutics, Inc. (CAPR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 0 $0 20,748 $3,319
2017-05 1,180,161 $3,658,499 0 $0 0 $0
2016-09 312,500 $1,000,000 0 $0 0 $0
2016-03 1,459,709 $3,503,299 0 $0 0 $0
2015-08 48,700 $209,347 0 $0 0 $0
2015-01 1,958,554 $6,899,983 0 $0 0 $0
2012-03 275,000 $0 0 $0 0 $0
2010-04 50,000 $0 0 $0 0 $0
2009-07 300,394 $0 0 $0 0 $0
2009-03 11,510 $8,752 0 $0 0 $0
2008-12 45,980 $46,389 0 $0 0 $0
2008-04 2,300 $10,679 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Nile Therapeutics, Inc. insiders (CAPR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-23 Manzo Louis Option Ex 20,748 .16 3,319
2017-05-09 Manzo Louis Buy 10,000 3.10 31,000
2017-05-09 Musket David B Buy 25,000 3.10 77,500
2017-05-09 Cedars Sinai Medical Center Buy 1,145,161 3.10 3,549,999
2016-09-21 Cedars Sinai Medical Center Buy 312,500 3.20 1,000,000
2016-03-16 Edward St. John, Llc Buy 833,332 2.40 1,999,996
2016-03-16 Manzo Louis Buy 100,000 2.40 240,000
2016-03-16 Bergmann Anthony (Vice President of Finance) Buy 2,030 2.40 4,872
2016-03-16 Krasney Karen (EVP, General Counsel) Buy 4,060 2.40 9,744
2016-03-16 Marban Linda (Chief Executive Officer) Buy 10,152 2.40 24,364
2016-03-16 Gershell Leland (CHIEF FINANCIAL OFFICER) Buy 2,100 2.40 5,040
2016-03-16 Cedars Sinai Medical Center Buy 416,666 2.40 999,998
2016-03-16 Grasmick Louis J Buy 91,369 2.40 219,285
2015-08-20 Grasmick Louis J Buy 9,260 4.08 37,753
2015-08-19 Marban Eduardo Buy 8,400 4.42 37,128
2015-08-19 Marban Linda (Chief Executive Officer) Buy 8,400 4.42 37,128
2015-08-19 Grasmick Louis J Buy 2,640 4.22 11,140
2015-08-18 Marban Eduardo Buy 10,000 4.31 43,099
2015-08-18 Marban Linda (Chief Executive Officer) Buy 10,000 4.31 43,099
2015-01-21 Edward St. John, Llc Buy 851,546 3.52 2,999,996
2015-01-21 Manzo Louis Buy 28,384 3.52 99,996
2015-01-21 Krasney Karen (EVP, General Counsel) Buy 7,096 3.52 24,999
2015-01-21 Musket David B Buy 70,962 3.52 249,999
2015-01-21 Cedars Sinai Medical Center Buy 851,546 3.52 2,999,996
2015-01-21 Grasmick Louis J Buy 141,924 3.52 499,998
2015-01-21 Kazam Joshua A Buy 7,096 3.52 24,999
2012-03-30 Lieu Hsiao (Executive VP, Clinical Dev.) Buy 12,500 .00 0
2012-03-30 Evans Daron (Chief Financial Officer) Buy 12,500 .00 0
2012-03-30 Kazam Joshua A (President & CEO) Buy 125,000 .00 0
2012-03-30 Brewer Richard B (Executive Chairman) Buy 125,000 .00 0
2010-04-22 Kazam Joshua A (Chief Executive Officer) Buy 50,000 .00 0
2009-07-07 Evans Daron (Chief Financial Officer) Buy 3,952 .00 0
2009-07-07 Kash Peter M (Director) Buy 98,814 .00 0
2009-07-07 Kazam Joshua A (Director) Buy 197,628 .00 0
2009-03-13 Evans Daron (Chief Financial Officer) Buy 5,000 .75 3,750
2009-03-12 Kazam Joshua A (Director) Buy 510 .75 382
2009-03-11 Evans Daron (Chief Financial Officer) Buy 6,000 .77 4,620
2008-12-16 Kazam Joshua A (Director) Buy 3,100 1.15 3,564
2008-12-16 Tanen David M (Director) Buy 2,500 1.15 2,875
2008-12-15 Kazam Joshua A (Director) Buy 2,500 1.05 2,625
2008-12-15 Tanen David M (Director) Buy 2,500 1.04 2,612
2008-12-12 Evans Daron (Chief Financial Officer) Buy 4,186 .97 4,081
2008-12-12 Strumph Peter M (Chief Executive Officer) Buy 3,000 .90 2,685
2008-12-12 Kash Peter M (Director) Buy 4,000 1.23 4,900
2008-12-12 Kazam Joshua A (Director) Buy 4,100 1.44 5,904
2008-12-12 Tanen David M (Director) Buy 4,000 1.47 5,868
2008-12-11 Evans Daron (Chief Financial Officer) Buy 3,814 .68 2,574
2008-12-11 Strumph Peter M (Chief Executive Officer) Buy 3,580 .60 2,155
2008-12-11 Kash Peter M (Director) Buy 600 .68 408
2008-12-11 Kazam Joshua A (Director) Buy 4,100 .82 3,374
2008-12-11 Tanen David M (Director) Buy 4,000 .69 2,764
2008-04-15 Schafer Gregory W (Director) Buy 100 4.60 459
2008-04-14 Evans Daron (Chief Financial Officer) Buy 800 4.55 3,640
2008-04-14 Strumph Peter M (Chief Executive Officer) Buy 1,400 4.70 6,580

Insider trading activities including stock purchases, stock sales, and option exercises of CAPR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nile Therapeutics, Inc. (symbol CAPR, CIK number 1133869) see the Securities and Exchange Commission (SEC) website.